Growth Metrics

Armata Pharmaceuticals (ARMP) Total Current Liabilities (2016 - 2018)

Historic Total Current Liabilities for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to $2.5 million.

  • Armata Pharmaceuticals' Total Current Liabilities fell 48.45% to $2.5 million in Q3 2018 from the same period last year, while for Sep 2018 it was $2.5 million, marking a year-over-year decrease of 48.45%. This contributed to the annual value of $2.0 million for FY2017, which is 4437.54% down from last year.
  • Armata Pharmaceuticals' Total Current Liabilities amounted to $2.5 million in Q3 2018, which was down 48.45% from $2.0 million recorded in Q2 2018.
  • In the past 5 years, Armata Pharmaceuticals' Total Current Liabilities registered a high of $3.7 million during Q2 2017, and its lowest value of $1.0 million during Q1 2014.
  • Moreover, its 5-year median value for Total Current Liabilities was $2.4 million (2015), whereas its average is $2.4 million.
  • Per our database at Business Quant, Armata Pharmaceuticals' Total Current Liabilities skyrocketed by 10682.26% in 2015 and then crashed by 4478.58% in 2018.
  • Quarter analysis of 5 years shows Armata Pharmaceuticals' Total Current Liabilities stood at $1.9 million in 2014, then rose by 27.68% to $2.4 million in 2015, then skyrocketed by 48.34% to $3.5 million in 2016, then crashed by 44.38% to $2.0 million in 2017, then rose by 25.25% to $2.5 million in 2018.
  • Its Total Current Liabilities was $2.5 million in Q3 2018, compared to $2.0 million in Q2 2018 and $1.8 million in Q1 2018.